Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Mantle-Cell 6Lymphoma, Non-Hodgkin 4Lymphoma 3Lymphoma, Follicular 2Vomiting 1Pyloric Stenosis, Hypertrophic 1Nausea 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell 1HIV Infections 1

Interventions

Temozolomide 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Cyclophosphamide 2venetoclax 1trametinib 1toripalimab 1sonidegib 1ribociclib 1fludarabine 1etoposide phosphate 1camrelizumab 1apatinib 1acalabrutinib 1Vincristine 1Thiotepa 1Therapeutics 1Telemedicine 1Tamoxifen 1Standard of Care 1Rituximab 1Radiotherapy 1R-CHOP protocol 1Patient Navigation 1Mesna 1Isotretinoin 1Interviews as Topic 1Immunotherapy, Adoptive 1Hydrocortisone 1Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pyloric Stenosis, Hypertrophic × R-CHOP protocol × Clear all
NCT04058470 2022-04-14

Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma

Sun Yat-sen University

Phase 1/2 Unknown
140 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡